Published in Hypertension on October 08, 2012
Sympathetic Activity and Renal Denervation (ReD) | NCT01355055
Future of catheter-based renal denervation: key issues to solve. Hypertens Res (2013) 2.03
Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens (2013) 1.88
Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res (2015) 1.45
The sympathetic nervous system alterations in human hypertension. Circ Res (2015) 1.28
Blood pressure and sympathetic nervous system response to renal denervation. Hypertension (2012) 1.08
Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients. Hypertension (2012) 1.07
Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. Hypertension (2012) 1.06
Role of renal sensory nerves in physiological and pathophysiological conditions. Am J Physiol Regul Integr Comp Physiol (2014) 1.02
Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome. J Am Heart Assoc (2013) 0.94
Chronic baroreflex activation restores spontaneous baroreflex control and variability of heart rate in obesity-induced hypertension. Am J Physiol Heart Circ Physiol (2013) 0.89
Renal denervation for the treatment of resistant hypertension: review and clinical perspective. Am J Physiol Renal Physiol (2015) 0.88
Unilateral renal denervation improves autonomic balance in conscious rabbits with chronic heart failure. Am J Physiol Regul Integr Comp Physiol (2013) 0.87
Can physiology zap therapeutic sweet spots in hypertension? Hypertension (2012) 0.85
Autonomic blockade improves insulin sensitivity in obese subjects. Hypertension (2014) 0.85
A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin. Am J Physiol Regul Integr Comp Physiol (2014) 0.82
The sympathetic nervous system in obesity hypertension. Curr Hypertens Rep (2013) 0.80
Con: renal denervation for all resistant hypertensive patients: the Emperor's new clothes. Nephrol Dial Transplant (2014) 0.80
Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease. Clin Kidney J (2013) 0.80
Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically? J Hum Hypertens (2014) 0.79
Differential role of afferent and efferent renal nerves in the maintenance of early- and late-phase Dahl S hypertension. Am J Physiol Regul Integr Comp Physiol (2015) 0.78
Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension. Curr Hypertens Rep (2013) 0.78
Renal denervation for the management of resistant hypertension. Integr Blood Press Control (2015) 0.78
Renal Denervation: A Potential Novel Treatment for Type 2 Diabetes Mellitus? Medicine (Baltimore) (2015) 0.77
The autonomic nervous system and renal physiology. Int J Nephrol Renovasc Dis (2013) 0.77
Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension. Front Physiol (2015) 0.76
Renal sympathetic nervous system and the effects of denervation on renal arteries. World J Cardiol (2014) 0.75
Rebuttal from L. E. K. Ratcliffe, W. Pijacka, F. D. McBryde, A. P. Abdala, D. J. Moraes, P. A. Sobotka, E. C. Hart, K. Narkiewicz, A. K. Nightingale and J. F. R. Paton. J Physiol (2014) 0.75
Response to catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to- control hypertensive patients: prospective case series. Hypertension (2013) 0.75
The role of renal denervation for the treatment of resistant hypertension. J Hum Hypertens (2013) 0.75
Novel strategies for treatment of resistant hypertension. Kidney Int Suppl (2011) (2013) 0.75
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension. Clin J Am Soc Nephrol (2015) 0.75
Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension. J Am Heart Assoc (2016) 0.75
Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success. World J Cardiol (2016) 0.75
Renal Denervation Promotes Atherosclerosis in Hypertensive Apolipoprotein E-Deficient Mice Infused with Angiotensin II. Front Physiol (2017) 0.75
Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation. J Am Soc Hypertens (2015) 0.75
Can we predict the blood pressure response to renal denervation? Auton Neurosci (2016) 0.75
Response to catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to- control hypertensive patients. Hypertension (2013) 0.75
Response to blood pressure and sympathetic nervous system response to renal denervation. Hypertension (2013) 0.75
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med (2011) 11.11
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature (2008) 10.73
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation (2007) 6.41
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell (2007) 5.85
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
The renal arterial resistance index and renal allograft survival. N Engl J Med (2003) 4.36
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res (2011) 3.88
New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation (2003) 3.79
MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res (2008) 3.30
Heavy metal--rely on gut feelings: novel diagnostic approach to test drug compliance in patients with lanthanum intake. Nephrol Dial Transplant (2007) 2.96
Activation of the peripheral endocannabinoid system in human obesity. Diabetes (2005) 2.90
Wegener's granulomatosis. Lancet (2006) 2.83
Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med (2010) 2.83
Pathogenesis and management of hypertension after kidney transplantation. J Hypertens (2011) 2.66
Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol (2002) 2.50
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes (2006) 2.40
Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension (2010) 2.38
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2011) 2.27
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature (2012) 2.27
Autonomic contribution to blood pressure and metabolism in obesity. Hypertension (2006) 2.25
Erythropoietin regulates endothelial progenitor cells. Blood (2003) 2.18
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation (2008) 2.18
Retinol-binding protein 4 in human obesity. Diabetes (2006) 2.17
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation (2003) 2.15
Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation (2012) 2.14
Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes (2007) 2.12
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation (2003) 2.12
Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension (2005) 2.01
Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet (2003) 2.00
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol (2005) 2.00
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol (2005) 1.99
The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J Hypertens (2003) 1.98
MicroRNA-24 regulates vascularity after myocardial infarction. Circulation (2011) 1.98
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. Cell Metab (2011) 1.98
Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. Circ Res (2010) 1.96
Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol (2007) 1.95
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol (2011) 1.94
Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care (2008) 1.94
ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke (2006) 1.88
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun (2012) 1.88
The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant (2009) 1.86
Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol (2009) 1.86
Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension (2006) 1.85
Autonomic nervous system and blood pressure regulation in RGS2-deficient mice. Am J Physiol Regul Integr Comp Physiol (2005) 1.84
Lung-targeted RNA interference against angiopoietin-2 ameliorates multiple organ dysfunction and death in sepsis. Crit Care Med (2014) 1.83
Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med (2007) 1.83
Nephrogenesis is induced by partial nephrectomy in the elasmobranch Leucoraja erinacea. J Am Soc Nephrol (2003) 1.83
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci (2011) 1.82
Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation (2004) 1.81
Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res (2008) 1.80
Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation (2003) 1.79
Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79
Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Circulation (2010) 1.76
Water ingestion as prophylaxis against syncope. Circulation (2003) 1.76
Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation (2005) 1.75
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol (2005) 1.74
Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation (2009) 1.73
Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol (2008) 1.72
Plasma exchange for primary autoimmune autonomic failure. N Engl J Med (2005) 1.71
Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension (2007) 1.70
Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol (2002) 1.70
Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction. Hypertension (2007) 1.68
Eligibility for renal denervation: experience at 11 European expert centers. Hypertension (2014) 1.68
MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol (2011) 1.65
Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. Cardiovasc Res (2006) 1.65
The BK channel beta1 subunit gene is associated with human baroreflex and blood pressure regulation. J Hypertens (2002) 1.65
Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol (2007) 1.63
Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation (2003) 1.63
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int (2005) 1.63
Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res (2007) 1.61
Water drinking as a treatment for orthostatic syndromes. Am J Med (2002) 1.60
Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function. Hypertension (2011) 1.59
Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects. Clin Pharmacol Ther (2006) 1.59